Lexaria Bioscience (LEXX) Other Operating Expenses (2017 - 2021)
Lexaria Bioscience (LEXX) recorded Other Operating Expenses of $6,472 in fiscal Q3 2021 (quarter ended May 31, 2021), down 62.2% from $17,113 a year earlier and down 84.7% from the prior quarter.
Powered by 
Analysis
Lexaria Bioscience (LEXX) Other Operating Expenses (2017 - 2021) Analysis & Trends
For FY2020 (ended Aug 31, 2020), Lexaria Bioscience reported Other Operating Expenses of $78,650, down 21.8% from FY2019.
- Annual Other Operating Expenses has a four-year compound annual growth rate of -4.8% (FY2016 to FY2020).
- Across earlier fiscal years, Other Operating Expenses came in at $100,587 in FY2019 (+1.4%), $99,236 in FY2018 (+33.9%), $74,087 in FY2017 (-22.8%) and $95,921 in FY2016.
- The fiscal Q3 2021 figure is the lowest quarterly Other Operating Expenses in data going back to fiscal Q3 2017.
- On a year-over-year basis, Other Operating Expenses rose in five of the last eight quarters, with growth averaging 5.2%.
- Peak year-over-year performance for Other Operating Expenses in the last five years was growth of 100.5% in fiscal Q2 2021, against a decline of 97.4% in fiscal Q4 2018 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at $42,282 (Q2 2021), $15,628 (Q1 2021) and $32,472 (Q4 2020).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Lexaria Bioscience | 3.26 Mn | -12.39 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| May 31, 2021 | 6,472.00 |
| Feb 28, 2021 | 42,282.00 |
| Nov 30, 2020 | 15,628.00 |
| Aug 31, 2020 | 32,472.00 |
| May 31, 2020 | 17,113.00 |
| Feb 29, 2020 | 21,087.00 |
| Nov 30, 2019 | 21,853.00 |
| Aug 31, 2019 | 27,717.00 |
| May 31, 2019 | 33,371.00 |
| Feb 28, 2019 | 20,293.00 |
| Nov 30, 2018 | 19,206.00 |
| Aug 31, 2018 | 19,055.00 |
| May 31, 2018 | 29,804.00 |
| Feb 28, 2018 | 22,544.00 |
| Nov 30, 2017 | 27,833.00 |
| Aug 31, 2017 | 727,596.00 |
| May 31, 2017 | 364,156.00 |
API Access
Lexaria Bioscience Other Operating Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=LEXX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-operating-expenses", "ticker": "LEXX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=LEXX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();